title: Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE.
abstract: Endometrial cancer is the fourth most common female malignancy in women in developed countries. Estrogen, and to a lesser degree, progesterone, regulate specific target genes that are involved in endometrial tumorigenesis. A family of proteases involved in cellular proliferation, extracellular matrix degradation and thus, implicated in tumorigenesis, and regulated by estrogen and progesterone in a number of systems, are the tissue kallikreins (KLKs). KLK4, a new member of the KLK gene family, was found to be expressed to varying levels in a number of endometrial cancer cell lines- HEC1A, HEC1B, Ishikawa, RL95-2 and KLE- at both the mRNA and protein level. On the addition of 10 nmol/L estradiol, progesterone, or a combination of both over a 48 h period, an increase in the intracellular protein levels of K4 were observed when compared to the control (untreated) cells. We have also identified a novel KLK4 transcript with a complete exon 4 deletion. The significance of this alternative transcript, which would give rise to a truncated protein without a serine residue (which is essential for catalytic activity), is yet to be established. These cell lines now provide a model system to study the role of KLK4 and the molecular mechanisms of KLK4 regulation by estrogen and progesterone, in endometrial tumorigenesis.
authors.affiliation: Centre for Molecular Biotechnology, School of Life Sciences, Queensland University of Technology, Brisbane, QLD, 4001, Australia.
authors.forename: S A
authors.initials: SA
authors.lastname: Myers
authors.forename: J A
authors.initials: JA
authors.lastname: Clements
mesh_terms: D000595:Amino Acid Sequence; D015139:Blotting, Southern; D015153:Blotting, Western; D016889:Endometrial Neoplasms / Q000378:metabolism*; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D007610:Kallikreins / Q000235:genetics* / Q000502:physiology; D008969:Molecular Sequence Data; D011374:Progesterone / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D004967:Estrogens; D011374:Progesterone; D007610:Kallikreins